Login here
Register Free
MENU
September 2023 - September 2024

Precision Medicine in Oncology

The latest Diaceutics virtual event, “Precision medicine in oncology”, will allow you to join the forefront of cancer testing and treatment, with a series of 8 live webinars, culminating in a full day true-to-life virtual event. During these events, you’ll get exclusive access to clinical insights from top European lab experts.

This series of webinars will cover cutting-edge topics including immunotherapy, liquid biopsy, pre-analytical phase, NGS, cytology, and CE-IVDR. These topics are revolutionizing cancer analysis and diagnostics. During this series of events, you can learn about the latest technologies and tools being used in this field.

Attendees can participate in interactive sessions and engage in real-time Q&A sessions with the expert speakers, providing a chance to ask questions and gain a deeper insight and understanding of these increasingly relevant topics.

Join us for our events that are designed specifically for laboratory professionals, pathologists, and anyone involved in oncology diagnostics and treatment. Stay up to date with the latest developments in precision medicine and be part of shaping the future of cancer treatment. Don’t miss out on this exciting opportunity to connect with experts in the field and take your knowledge to the next level.

Speakers
  • Presenter headshot of dr_luis_pazares

    Dr. Luis Paz-Ares

    Chair of the Medical Oncology Department, Hospital Universitario 12 de Octubre
    Associate Professor at the Universidad Complutense de Madrid
    Head of the Lung Cancer Unit at the CNIO (Spanish National Cancer Research Center), Madrid
    President of ASEICA (Spanish Association of Cancer Research)
    BIOGRAPHY
  • Presenter headshot of dr_philippe_taniere

    Dr. Philippe Taniere

    Consultant Histopathologist
    Clinical Service Lead - Molecular Pathology Diagnostic Service
    University Hospitals Birmingham
    BIOGRAPHY

Event Series

Join us for an illuminating webinar featuring two distinguished experts in the field of oncohematology as they delve into the cutting-edge realm of liquid biopsies, their pivotal role in the detection of minimal residual disease (MRD) and investigate their role in the diagnostics of aggressive B cell lymphoma and multiple myeloma.  

Dr. Sven Borchmann from the University of Cologne will guide participants through the revolutionary world of liquid biopsies as applied to B cell lymphoma. Attendees will gain a deep understanding of Minimal Residual Disease (MRD) and its profound implications in oncohematology, particularly aggressive B cell lymphoma. Dr. Borchmann will shed light on the innovative techniques for MRD measurement using circulating tumor DNA and provide a glimpse into the exciting future prospects in this field. 

Prof. Mattia D'Agostino from the University of Turin, focuses on liquid biopsy techniques in the context of multiple myeloma and precision medicine. Prof. D'Agostino will unravel the diverse techniques used in liquid biopsies and their applicability in multiple myeloma. Participants will discover how liquid biopsies are reshaping the landscape of multiple myeloma diagnosis and their critical role in monitoring MRD in this patient population. The session will conclude by looking ahead at the potential of liquid biopsies to revolutionize precision medicine in the context of multiple myeloma, promising a forward-thinking perspective for all attendees.  

Don't miss this opportunity to gain comprehensive insights into the latest advancements in liquid biopsy technology and its transformative impact on oncohematology diagnostics and treatment. Join us for this enlightening webinar with two leading experts who are driving innovation in the field. 

Attendees can participate in interactive sessions and engage in real-time Q&A sessions with the expert speakers, providing a chance to ask questions and gain a deeper insight and understanding of these increasingly relevant topics. Register now to secure your spot in this groundbreaking webinar and be at the forefront of the future of oncohematology diagnostics and precision medicine.

  • SEP 28, 2023 12:30 PM CEST

    Immunotherapy Insights: Biomarker Testing and Multi-Disease Treatment Options

    SEE ABSTRACT
    Dr. Luis Paz-Ares
    Chair of the Medical Oncology Department, Hospital Universitario 12 de Octubre
    Associate Professor at the Universidad Complutense de Madrid
    Head of the Lung Cancer Unit at the CNIO (Spanish National Cancer Research Center), Madrid
    President of ASEICA (Spanish Association of Cancer Research)
    BIOGRAPHY
    Dr. Philippe Taniere
    Consultant Histopathologist
    Clinical Service Lead - Molecular Pathology Diagnostic Service
    University Hospitals Birmingham
    BIOGRAPHY
About DXRX

DXRX is a digital gateway that answers the needs of all precision medicine stakeholders, integrating multiple pipelines of real-world diagnostic testing data from a global network of labs.

DXRX places labs at the center of the network, unlocking collaboration opportunities with other labs and world-leading pharma. We aim to connect labs, pharma and diagnostic companies at a local, national, and global level.

DXRX has been purpose built to address challenges in testing that labs face every day and offers collaboration opportunities designed to solve each barrier.

By signing up to DXRX, you have the opportunity to:

  • Connect with other labs to share resources and learning, register interest in partnering opportunities on new biomarker launches,
  • Be the first to hear about exciting sponsored scientific studies and DXRX collaborations,
  • Access rich data insights and access aggregated data at a global level when you participate in our data strategies.
  • When you join DXRX, The Diagnostic Network® , you’ll be joining a movement, along with thousands of other labs and the world’s leading pharmaceutical companies to get every patient the treatment they deserve.

 

Help

Demographics
599 Attendees